Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Sell
31
HHS Quote, Financials, Valuation and Earnings
Last price:
$4.98
Seasonality move
:
1.23%
Day range:
$4.50 - $5.02
52-week range:
$4.27 - $8.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.19x
P/B ratio:
1.62x
Volume:
111.6K
Avg. volume:
27.2K
1-year change:
-33.29%
Market cap:
$35.1M
Revenue:
$185.2M
EPS (TTM):
-$4.17
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Harte-Hanks has 266.88% upside to fair value with a price target of -- per share.
HHS vs. S&P 500
-
Over the past 5 trading days, Harte-Hanks has overperformed the S&P 500 by 4.23% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Harte-Hanks does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Harte-Hanks revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported revenues of $47.1M.
Earnings Growth
-
Harte-Hanks earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Harte-Hanks reported earnings per share of -$0.33.
Enterprise value:
25.2M
EV / Invested capital:
--
Price / LTM sales:
0.19x
EV / EBIT:
4.06x
EV / Revenue:
0.14x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-3.74x
Price / Operating cash flow:
167.22x
Enterprise value / EBITDA:
2.38x
Gross Profit (TTM):
$128.6M
Return On Assets:
-27.25%
Net Income Margin (TTM):
-16.36%
Return On Equity:
-146.84%
Return On Invested Capital:
-146.84%
Operating Margin:
4.03%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $206.3M | $191.5M | $185.2M | $49.5M | $47.1M | |
| Gross Profit | $144.3M | $131.9M | $128.6M | $33.1M | $32.3M | |
| Operating Income | $15.1M | $9M | $7.7M | $3.4M | $1.9M | |
| EBITDA | $17.8M | $13.3M | $10.6M | $4.6M | $3.2M | |
| Diluted EPS | $4.76 | -$0.22 | -$4.17 | -$0.27 | -$0.33 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $86.2M | $75.4M | $66.3M | $65.2M | $53.6M | |
| Total Assets | $119.5M | $107.9M | $120M | $122.8M | $101.8M | |
| Current Liabilities | $47.2M | $42.4M | $43.6M | $48.1M | $35.1M | |
| Total Liabilities | $162.9M | $122.9M | $101.2M | $102.9M | $80.1M | |
| Total Equity | -$43.4M | -$15M | $18.8M | $19.9M | $21.7M | |
| Total Debt | $27.1M | $5M | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $28.8M | $10.5M | -$3M | $4.4M | $4M | |
| Cash From Investing | -$11.5M | -$2.3M | -$3.7M | -$832K | -$626K | |
| Cash From Financing | -$15.8M | -$3.2M | -$419K | -$86K | -$94K | |
| Free Cash Flow | $23M | $7.7M | -$6.7M | $3M | $3.4M | |
HHS
Sector
Market Cap
$35.1M
$77.9M
Price % of 52-Week High
53.78%
63.28%
Dividend Yield
0%
0%
Shareholder Yield
0.78%
3.11%
1-Year Price Total Return
-33.29%
-15%
Beta (5-Year)
0.098
0.579
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.61
200-day SMA
Sell
Level
$6.24
Bollinger Bands (100)
Sell
Level
4.71 - 5.49
Chaikin Money Flow
Sell
Level
-7.6M
20-day SMA
Buy
Level
$4.61
Relative Strength Index (RSI14)
Buy
Level
52.31
ADX Line
Buy
Level
18.35
Williams %R
Neutral
Level
-33.4538
50-day SMA
Sell
Level
$4.81
MACD (12, 26)
Sell
Level
-0.04
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Sell
Level
-18.5M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (13.7752)
Sell
CA Score
(Annual)
Level (-0.955)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (4.0254)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
Stock Forecast FAQ
In the current month, HHS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HHS average analyst price target in the past 3 months is --.
-
Where Will Harte-Hanks Stock Be In 1 Year?
According to analysts, the consensus estimate is that Harte-Hanks share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Harte-Hanks?
Analysts are divided on their view about Harte-Hanks share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Harte-Hanks is a Sell and believe this share price will drop from its current level to --.
-
What Is Harte-Hanks's Price Target?
The price target for Harte-Hanks over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HHS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Harte-Hanks is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HHS?
You can purchase shares of Harte-Hanks via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Harte-Hanks shares.
-
What Is The Harte-Hanks Share Price Today?
Harte-Hanks was last trading at $4.98 per share. This represents the most recent stock quote for Harte-Hanks. Yesterday, Harte-Hanks closed at $4.77 per share.
-
How To Buy Harte-Hanks Stock Online?
In order to purchase Harte-Hanks stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
39
RGC alert for Apr 29
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
76
EXOD alert for Apr 29
Exodus Movement [EXOD] is down 3.2% over the past day.
Sell
48
SBGSY alert for Apr 29
Schneider Electric SE [SBGSY] is down 0.17% over the past day.
